EGFR and cancer: An explanation of how the acquired TKI resistance develops is that the EGFR’s kinase dependent function is shifted toward its KID pro-survival function, giving cancer cells that are dependent on EGFR kinase activity for growth a way to establish alternative proliferative mechanisms, bypassing the EGFR kinase-dominated pathway that is under constant exposure to TKIs.